Jose Javier, GSP, two impacts. 
ADX- 2191 is also the subject of our new clinical program in primary vitreoretinal lymphoma or PVRL, 
Jonas Oscar from Bernstein asked two more technical questions with respect to the petition namely, 
next question is from Gordon Lee, with BTG. Thanks. 
Um, my second question is, uh, I understand that the shares you own in Grupo SURA uh, are used as collateral for the credit lines you, you have in place. 
kind of how each piece performed, if you can give it a little color on that. We have some information from IRI, but I'm curious if you have better information than we have. 
I would now like to turn the conference over to Scott Dudley, Managing Director Investor Relations. Please go ahead. 
He has had executive leadership roles with XPO logistics, Dallas Bar, Reynolds Group and Alcoa. 
for DSUVIA's placement in all of the US Army's sets, kits and outfits, or SKO's associated with future deployments. 
we'll look forward to additional results next year from the CCGA stuff, study three and Pathfinder to further support the clinical validation of Galleri. 
We had new customers ranked from global tier one operators to electric co-ops, cooperatives, municipalities, cable MSO, and regional broadband providers. 
Hi, and good morning, uh, Fabio. This is Antonio Hernandez in behalf of, of Ben Theurer. 
Um, perhaps you could help us bridge these results which I think are about $41 WTI to, um, to the seven billion 
Our optimism for the use of RASP as an objective sign of dry disease is supported by data from our successful Phase IIA trial 
Gentlemen, there are no more questions registered at this time. I would like to turn the conference back over to Fabio Sandri for closing remarks. 
And you're saying Muscle Shoals is doing well. It seems like the US is going, going well. I think Crown yesterday mentioned that Southern Europe was weak. 
That's it. Thanks. Thanks, Josh. Your next question comes from the line of David Gagliano from BMO Capital Markets. Your line is open. Great. Thanks for taking my questions. 
Uh, Alexandra, thank you for, for the question. I would like Tomas Restrepo to review on our behalf. Uh, how are things evolving in Colombia 
Our response speaks to how the IRX toolkit has effectively helped us plan, accelerate and adapt our actions 
Second one is, uh, you are talking, and, of course, there is DSO pressure. 
Aerospace shipments fell 37% compared to last year as aerospace OEMs and distributors began to reduce orders. 
to say that if the power price goes negative for more than six hours, then basically CFD <inaudible> is to apply for o, for that that time. 
And with that, I'd now like to turn the program over to Don Casey, Chief Executive Officer, Dentsply Sirona. 
Um, and then, question on RDOF. 
The second group is the employees of Dentsply Sirona. Over the last six months, they have been challenged in truly unprecedented ways. 
For additional details on these risks and uncertainties, please see Nexstar's annual report on Form 10K 
as you look forward, kind of the Galleri launches, there's gonna be investments around a number of factors. 
